Filspari is a prescription medication used to treat a specific kidney condition called IgA nephropathy, sometimes called IgA kidney disease. Before exploring its side effects, it helps to understand what this medication actually does inside your body and why doctors prescribe it.
Learn When and How to Replace Fuel Pumps →
IgA nephropathy happens when a type of antibody called IgA builds up in the kidneys and causes inflammation. Over time, this inflammation can damage the kidney's filtering units and reduce how well your kidneys work. Filspari is designed to target a specific protein involved in this immune response, helping to slow or reduce the kidney damage that occurs with this condition.
The medication works by blocking a protein called BAFF (B-cell activating factor), which plays a role in how immune cells develop. By reducing BAFF activity, Filspari may help decrease the harmful immune response happening in the kidneys. Think of it like turning down the volume on an alarm system that's gone haywire—the goal is to quiet the overactive immune response without completely shutting down the immune system's ability to fight actual infections.
Filspari comes as an oral tablet and is taken by mouth, usually once daily. Your doctor will determine the right dose based on your specific situation, kidney function, and how your body responds to the medication. The medication takes weeks to show effects, so it's not something that works immediately like a pain reliever would.
Understanding how Filspari works is important because it helps explain why certain side effects might occur. Since the medication affects immune system function, many side effects relate to how your body fights infections or maintains normal immune responses. This context matters as you read through what specific side effects researchers and doctors have observed.
Practical Takeaway: Filspari is a targeted immune therapy for kidney disease that works slowly over weeks. Knowing that it affects immune function helps you understand the types of side effects that may happen and why monitoring is important.
When Filspari was studied in clinical trials before approval, researchers carefully tracked what happened to patients taking the medication. Some side effects occurred frequently enough that doctors consider them "common," though this doesn't mean everyone will experience them.
Free Guide to Sam's Club Payment Options →
Infection-related side effects topped the list of common reactions. Since Filspari modifies how the immune system works, upper respiratory infections (colds, sinus infections, bronchitis) occurred more often in people taking the medication compared to those taking a placebo. In clinical trials, respiratory tract infections were among the most frequently reported issues. Urinary tract infections also appeared more often. These infections weren't typically severe, but they happened more frequently than in the general population, which makes sense given that the medication affects immune response.
Gastrointestinal side effects also showed up regularly. Nausea, diarrhea, and abdominal discomfort were reported by a meaningful number of trial participants. Some people experienced decreased appetite or changes in how their digestive system worked. These symptoms were usually mild to moderate and often improved over time as patients' bodies adjusted to the medication.
Fatigue and general body aches appeared on the common side effects list as well. Some patients reported feeling more tired than usual or experiencing muscle and joint pain. Headaches were also documented in trial data, though they weren't typically severe.
It's important to note that "common" in medical terminology means the side effect occurred in a meaningful percentage of study participants—often anywhere from 5% to 25% depending on the specific side effect. This means that many people taking Filspari may not experience any particular common side effect, or they might experience only one or two while skipping others entirely.
Many common side effects tend to improve as your body adjusts to the medication during the first few weeks or months of treatment. Some people find that side effects decrease significantly after their body adapts. However, others may have side effects that persist for as long as they take the medication.
Practical Takeaway: Most common Filspari side effects relate to increased infection risk and digestive symptoms. These are generally mild to moderate and may improve over time as your body adjusts. Knowing which side effects are common helps you distinguish them from more serious reactions.
While common side effects are usually manageable, Filspari can occasionally cause more serious reactions that need immediate medical attention. Understanding the difference between annoying but manageable side effects and dangerous ones is critical for anyone taking this medication.
Learn How Subaru Remote Start Works →
Serious infections represent the most significant safety concern with Filspari. Because the medication suppresses certain parts of the immune response, patients may be at higher risk for infections that could become severe. This includes not just common colds, but potentially serious bacterial infections, viral infections, and other opportunistic infections. In rare cases, tuberculosis (TB) reactivation has been a concern with medications in this drug class, which is why doctors screen patients for TB before starting Filspari and may monitor for signs of TB during treatment.
Hepatotoxicity—damage to the liver—has been observed in some patients taking medications similar to Filspari. While it's not extremely common, liver function can be affected, which is why doctors typically order blood tests to monitor liver enzymes before you start taking Filspari and periodically during treatment. Signs that your liver might be affected include yellowing of the skin or eyes, dark urine, unusual bruising, persistent nausea, or abdominal pain on the right side where your liver is located.
Allergic reactions, including severe allergic reactions, can occur though they're relatively rare. Symptoms might include difficulty breathing, swelling of the face or throat, severe rash, or anaphylaxis. These require immediate emergency medical care.
Low blood counts (decreased white blood cells, red blood cells, or platelets) can happen with immune-modifying medications. If your body isn't making enough blood cells, you might notice unusual bruising, extreme fatigue, frequent infections, or unexplained bleeding. This is another reason blood work monitoring is important.
Filspari may also increase the risk of certain types of cancer over long-term use because of its effects on the immune system, though this is a theoretical concern based on how similar medications work rather than something definitively proven with Filspari specifically. This is why long-term monitoring and discussing cancer risk with your doctor matters.
The key point about serious side effects is that they're relatively uncommon, but when they do occur, they need prompt medical evaluation. Don't wait to see if these symptoms resolve on their own.
Practical Takeaway: Serious side effects with Filspari primarily involve infections, liver damage, allergic reactions, and blood count changes. These are less common than mild side effects but require immediate medical attention if they occur. Regular monitoring through blood work helps catch problems early.
Taking Filspari isn't a situation where you simply take a pill and forget about it. Your doctor will want to monitor how the medication affects your body through regular testing and check-ins. Understanding what these tests measure and why they matter helps you participate actively in your own care.
Learn How to Exit Android Safe Mode →
Blood work is the primary monitoring tool. Before you start Filspari, your doctor will order baseline blood tests to establish your starting point. These typically include tests for liver function (checking enzymes like ALT and AST), kidney function (measuring creatinine and estimated glomerular filtration rate), and complete blood count (CBC) to check your red blood cells, white blood cells, and platelets. These baseline measurements give your doctor something to compare against as you continue taking the medication.
During the first few months of treatment, blood work is usually done more frequently—perhaps monthly—to watch for any problems as your body adjusts to Filspari. After several months, if everything is stable, testing might happen less often, perhaps every three months or every six months. However, your specific monitoring schedule depends on your individual situation and what your doctor recommends.
Tuberculosis (TB) testing before starting Filspari is standard practice. Your doctor will typically perform a TB skin test or blood test called an interferon-gamma release assay (IGRA) to check if you have latent TB infection. If latent TB is found, you may need to start TB preventive treatment before beginning Filspari to reduce the risk of TB reactivation.
Kidney function
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.